Expression of NK cell markers in CD56dim and CD56bright cells from two healthy normal donors (N1, N2) and from the patient (P).

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

Open link

Publication date

February 2013

DOI

10.1371/journal.pone.0051677.t002

Abstract

Numbers correspond to the percentage of cells expressing the indicated marker.</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Expression of NK cell markers in CD56dim and CD56bright cells from two healthy normal donors (N1, N2) and from the patient (P).

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

Open link

Publication date

February 2013

DOI

10.1371/journal.pone.0051677.t002

Abstract

Numbers correspond to the percentage of cells expressing the indicated marker.</p

Extracted data

Henoch S. Hong (134667)
Fareed Ahmad (134672)
Johanna M. Eberhard (134677)
Nupur Bhatnagar (134681)
Benjamin A. Bollmann (134685)
Phillip Keudel (134688)
Matthias Ballmaier (108546)
Margot Zielinska-Skowronek (134691)
Reinhold E. Schmidt (134694)
Dirk Meyer-Olson (134697)

September 2012

(A) Representative flow cytometry plots defining CD56bright NK cells. Numbers indicate...

Expression of NKLRs on NK cells during activation and expansion.

Gal Markel (23163)
Rachel Seidman (372848)
Michal J. Besser (223576)
Naama Zabari (372850)
Rona Ortenberg (223561)
Ronnie Shapira (372851)
Avraham J. Treves (372852)
Ron Loewenthal (215204)
Arie Orenstein (200888)
Arnon Nagler (144514)
Jacob Schachter (197176)

February 2013

(A) Ex vivo expansion of peripheral blood NK cells. Figure shows the average results of NK cultur...

IL-15 DCs induce an activated cytotoxic effector phenotype in NK cells and enlarge the proportion of the CD56bright NK cell subset.

Sébastien Anguille (106649)
Heleen H. Van Acker (736251)
Johan Van den Bergh (736252)
Yannick Willemen (736253)
Herman Goossens (305529)
Viggo F. Van Tendeloo (106663)
Evelien L. Smits (106665)
Zwi N. Berneman (106666)
Eva Lion (106651)

May 2015

(A) Bar graphs showing the MFI (± SEM) of CD56, CD69, CD25, HLA-DR, NKG2D, NKp30 and NKp46...

Expression of NK cell receptors.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

PBMCs from at least 3 different normal(healthy) donors (N) and from different blood draws from di...

Phenotype of NK cells.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

A) PBMCs from two normal (healthy) donors (N1 and N2) and from the patient (P) were staine...

NK-cells from IFN-OFF patients have a mature phenotype.

Mette Ilander (208591)
Anna Kreutzman (210606)
Peter Rohon (210611)
Teresa Melo (517725)
Edgar Faber (210615)
Kimmo Porkka (210641)
Jukka Vakkila (210636)
Satu Mustjoki (210642)

January 2014

NK-cell proportions and surface markers CD62L, CD57 and CD27 were analyzed with flow cytometry an...

NK NKLR expression profile in healthy donors vs. melanoma patients.

Gal Markel (23163)
Rachel Seidman (372848)
Michal J. Besser (223576)
Naama Zabari (372850)
Rona Ortenberg (223561)
Ronnie Shapira (372851)
Avraham J. Treves (372852)
Ron Loewenthal (215204)
Arie Orenstein (200888)
Arnon Nagler (144514)
Jacob Schachter (197176)

February 2013

The expression profile of each NKLR is presented in an independent panel, as indicated. Each dot ...

Phenotype of NK cells stimulated with IL-2 or IL-15.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

PBMCs from two healthy normal donors (N1 and N2) and from the patient (P) (A, B) or...

Analysis of blood NK cells from donors and melanoma patients.

Giulia Fregni (349403)
Meriem Messaoudene (473889)
Emmanuelle Fourmentraux-Neves (473890)
Sarra Mazouz-Dorval (473891)
Johan Chanal (473892)
Eve Maubec (228313)
Eduardo Marinho (243034)
Isabelle Scheer-Senyarich (473893)
Isabelle Cremer (48261)
Marie-Françoise Avril (228331)
Anne Caignard (332149)

October 2013

(A) Proportions (left) and absolute numbers (right) of NK cells among PBMC from donors and melano...

Percentage of CD16+, CD57+, CD158+ and CD62L+ NK cells before and after stimulation with IL-2 or IL-15.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

A) Percentage of CD16+, CD57+ and CD158+ cells before (−)...

Expression of CD133, CD33, CD244 and NKG2A within the NK cell developmental stages in bone marrow (BM) (n = 5).

Diana N. Eissens (185247)
Jan Spanholtz (185249)
Arnold van der Meer (27491)
Bram van Cranenbroek (87733)
Harry Dolstra (116019)
Jaap Kwekkeboom (185252)
Frank W. M. B. Preijers (185256)
Irma Joosten (27492)

February 2012

Left panels show the percentages of cells positive for the specific markers. Right panels show th...

Expression of KIR, NKG2A/C, NCR, NKG2D and CD244 within the CD56dimCD16+ NK cell subset of committed NK cells in bone marrow (BM), cord blood (CB), peripheral blood (PB), inguinal LN (inLN), liver LN (liLN) and spleen (SPL) (all n = 5).

Diana N. Eissens (185247)
Jan Spanholtz (185249)
Arnold van der Meer (27491)
Bram van Cranenbroek (87733)
Harry Dolstra (116019)
Jaap Kwekkeboom (185252)
Frank W. M. B. Preijers (185256)
Irma Joosten (27492)

February 2012

(A) Shown are the percentages of CD56dimCD16+ cells positive for each speci...

Significantly different markers by frequency within CD56bright NK cells of healthy adults and children.

Sanjana Mahapatra (4325824)
Emily M. Mace (125724)
Charles G. Minard (4325815)
Lisa R. Forbes (4325830)
Alexander Vargas-Hernandez (4325818)
Teresa K. Duryea (4325821)
George Makedonas (248246)
Pinaki P. Banerjee (125727)
William T. Shearer (4325827)
Jordan S. Orange (125729)

August 2017

Significantly different markers by frequency within CD56bright NK cells of healthy adu...

Loss of CCR7-expressing CD56bright NK cells correlates with clinical disease markers.

Henoch S. Hong (134667)
Fareed Ahmad (134672)
Johanna M. Eberhard (134677)
Nupur Bhatnagar (134681)
Benjamin A. Bollmann (134685)
Phillip Keudel (134688)
Matthias Ballmaier (108546)
Margot Zielinska-Skowronek (134691)
Reinhold E. Schmidt (134694)
Dirk Meyer-Olson (134697)

September 2012

(A) Representative flow cytometry plots defining CD56bright NK cells. Numbers indicate...

Expression of NKLRs on NK cells during activation and expansion.

Gal Markel (23163)
Rachel Seidman (372848)
Michal J. Besser (223576)
Naama Zabari (372850)
Rona Ortenberg (223561)
Ronnie Shapira (372851)
Avraham J. Treves (372852)
Ron Loewenthal (215204)
Arie Orenstein (200888)
Arnon Nagler (144514)
Jacob Schachter (197176)

February 2013

(A) Ex vivo expansion of peripheral blood NK cells. Figure shows the average results of NK cultur...

IL-15 DCs induce an activated cytotoxic effector phenotype in NK cells and enlarge the proportion of the CD56bright NK cell subset.

Sébastien Anguille (106649)
Heleen H. Van Acker (736251)
Johan Van den Bergh (736252)
Yannick Willemen (736253)
Herman Goossens (305529)
Viggo F. Van Tendeloo (106663)
Evelien L. Smits (106665)
Zwi N. Berneman (106666)
Eva Lion (106651)

May 2015

(A) Bar graphs showing the MFI (± SEM) of CD56, CD69, CD25, HLA-DR, NKG2D, NKp30 and NKp46...

Expression of NK cell receptors.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

PBMCs from at least 3 different normal(healthy) donors (N) and from different blood draws from di...

Phenotype of NK cells.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

A) PBMCs from two normal (healthy) donors (N1 and N2) and from the patient (P) were staine...

NK NKLR expression profile in healthy donors vs. melanoma patients.

Gal Markel (23163)
Rachel Seidman (372848)
Michal J. Besser (223576)
Naama Zabari (372850)
Rona Ortenberg (223561)
Ronnie Shapira (372851)
Avraham J. Treves (372852)
Ron Loewenthal (215204)
Arie Orenstein (200888)
Arnon Nagler (144514)
Jacob Schachter (197176)

February 2013

The expression profile of each NKLR is presented in an independent panel, as indicated. Each dot ...

Phenotype of NK cells stimulated with IL-2 or IL-15.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

PBMCs from two healthy normal donors (N1 and N2) and from the patient (P) (A, B) or...

Analysis of blood NK cells from donors and melanoma patients.

Giulia Fregni (349403)
Meriem Messaoudene (473889)
Emmanuelle Fourmentraux-Neves (473890)
Sarra Mazouz-Dorval (473891)
Johan Chanal (473892)
Eve Maubec (228313)
Eduardo Marinho (243034)
Isabelle Scheer-Senyarich (473893)
Isabelle Cremer (48261)
Marie-Françoise Avril (228331)
Anne Caignard (332149)

October 2013

(A) Proportions (left) and absolute numbers (right) of NK cells among PBMC from donors and melano...

Percentage of CD16+, CD57+, CD158+ and CD62L+ NK cells before and after stimulation with IL-2 or IL-15.

Carolina Inés Domaica (294947)
Mercedes Beatriz Fuertes (294948)
Ignacio Uriarte (294949)
María Victoria Girart (294950)
Jessica Sardañons (294952)
Dorina Ileana Comas (294954)
Daniela Di Giovanni (294956)
María Isabel Gaillard (294958)
Liliana Bezrodnik (294960)
Norberto Walter Zwirner (294962)

February 2013

A) Percentage of CD16+, CD57+ and CD158+ cells before (−)...

Expression of CD133, CD33, CD244 and NKG2A within the NK cell developmental stages in bone marrow (BM) (n = 5).

Diana N. Eissens (185247)
Jan Spanholtz (185249)
Arnold van der Meer (27491)
Bram van Cranenbroek (87733)
Harry Dolstra (116019)
Jaap Kwekkeboom (185252)
Frank W. M. B. Preijers (185256)
Irma Joosten (27492)

February 2012

Left panels show the percentages of cells positive for the specific markers. Right panels show th...

Diana N. Eissens (185247)
Jan Spanholtz (185249)
Arnold van der Meer (27491)
Bram van Cranenbroek (87733)
Harry Dolstra (116019)
Jaap Kwekkeboom (185252)
Frank W. M. B. Preijers (185256)
Irma Joosten (27492)

February 2012

(A) Shown are the percentages of CD56dimCD16+ cells positive for each speci...

Significantly different markers by frequency within CD56bright NK cells of healthy adults and children.

Sanjana Mahapatra (4325824)
Emily M. Mace (125724)
Charles G. Minard (4325815)
Lisa R. Forbes (4325830)
Alexander Vargas-Hernandez (4325818)
Teresa K. Duryea (4325821)
George Makedonas (248246)
Pinaki P. Banerjee (125727)
William T. Shearer (4325827)
Jordan S. Orange (125729)

August 2017

Significantly different markers by frequency within CD56bright NK cells of healthy adu...

Loss of CCR7-expressing CD56bright NK cells correlates with clinical disease markers.

Henoch S. Hong (134667)
Fareed Ahmad (134672)
Johanna M. Eberhard (134677)
Nupur Bhatnagar (134681)
Benjamin A. Bollmann (134685)
Phillip Keudel (134688)
Matthias Ballmaier (108546)
Margot Zielinska-Skowronek (134691)
Reinhold E. Schmidt (134694)
Dirk Meyer-Olson (134697)

September 2012

(A) Representative flow cytometry plots defining CD56bright NK cells. Numbers indicate...

Expression of NKLRs on NK cells during activation and expansion.

Gal Markel (23163)
Rachel Seidman (372848)
Michal J. Besser (223576)
Naama Zabari (372850)
Rona Ortenberg (223561)
Ronnie Shapira (372851)
Avraham J. Treves (372852)
Ron Loewenthal (215204)
Arie Orenstein (200888)
Arnon Nagler (144514)
Jacob Schachter (197176)

February 2013

(A) Ex vivo expansion of peripheral blood NK cells. Figure shows the average results of NK cultur...

IL-15 DCs induce an activated cytotoxic effector phenotype in NK cells and enlarge the proportion of the CD56bright NK cell subset.

Sébastien Anguille (106649)
Heleen H. Van Acker (736251)
Johan Van den Bergh (736252)
Yannick Willemen (736253)
Herman Goossens (305529)
Viggo F. Van Tendeloo (106663)
Evelien L. Smits (106665)
Zwi N. Berneman (106666)
Eva Lion (106651)

May 2015

(A) Bar graphs showing the MFI (± SEM) of CD56, CD69, CD25, HLA-DR, NKG2D, NKp30 and NKp46...

Expression of NK cell markers in CD56dim and CD56bright cells from two healthy normal donors (N1, N2) and from the patient (P).

Abstract

Extracted data

Expression of NK cell markers in CD56dim and CD56bright cells from two healthy normal donors (N1, N2) and from the patient (P).

Abstract

Extracted data

Related items

Related items